Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1.Feasibility outcomes will be time taken to recruit 100 patients and compliance for colchicine <br/ >2.Safety outcome includes treatment emergent adverse effects due to study drug and cessation of study drug due to adverse events <br/ >3. Efficacy outcome includes incidence of COVID infection between the 2 groups. <br/ >Timepoint: 6 Months <br/ >	1.Feasibility outcomes will be time taken to recruit 100 patients and compliance for colchicine <br/ >2.Safety outcome includes treatment emergent adverse effects due to study drug and cessation of study drug due to adverse events <br/ >3. Efficacy outcome includes incidence of COVID infection between the 2 groups. <br/ >Timepoint: 6 Months <br/ >
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Dec. 16, 2020, 10:47 a.m.	oms	1.Feasibility outcomes will be time taken to recruit 100 patients and compliance for colchicine <br/ >2.Safety outcome includes treatment emergent adverse effects due to study drug and cessation of study drug due to adverse events <br/ >3. Efficacy outcome includes incidence of COVID infection between the 2 groups. <br/ >Timepoint: 6 Months <br/ >	1.Feasibility outcomes will be time taken to recruit 100 patients and compliance for colchicine <br/ >2.Safety outcome includes treatment emergent adverse effects due to study drug and cessation of study drug due to adverse events <br/ >3. Efficacy outcome includes incidence of COVID infection between the 2 groups. <br/ >Timepoint: 6 Months <br/ >